NASDAQ · Biotechnology

ALEC (ALEC) Stock

$2.72 +13.33% NASDAQ: ALEC Healthcare

Valuation

MetricValue
Price$2.72
Market Cap$301.99M
P/E Ratio-1.58
P/B Ratio7.83
P/S Ratio12.78
EPS (TTM)$-1.39
52-Week High$3.40
52-Week Low$1.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-461.29%
ROA-48.81%
ROCE-486.67%
Gross Margin-695.24%
Operating Margin-695.24%
Net Margin-6.81%
Debt/Equity3.33
Current Ratio3.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$207.0M$134.0M$97.0M$101.0M$21.0M
Operating Profit$-37.0M$-138.0M$-152.0M$-145.0M$-146.0M
Net Profit$-36.0M$-133.0M$-130.0M$-119.0M$-143.0M
EPS$-0.45$-1.62$-1.56$-1.23$-1.39
Op Margin-18.0%-103.2%-156.3%-144.2%-692.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$815.0M$788.0M$622.0M$468.0M$293.0M
Total Liabilities$514.0M$573.0M$488.0M$342.0M$263.0M
Cash$329.0M$154.0M$75.0M$33.0M$66.0M
Borrowings$48.0M$43.0M$39.0M$43.0M$36.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$299.0M$-20.0M$-184.0M$-230.0M$-184.0M
Investing Cash Flow$-53.0M$-163.0M$100.0M$106.0M$197.0M
Financing Cash Flow$30.0M$0$0$1.0M$0
Net Cash Flow$279.0M$-175.0M$-80.0M$-41.0M$33.0M
Free Cash Flow$295.0M$-24.0M$-187.0M$-231.0M$-184.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-73.59%
Quick Ratio5.25
Interest Coverage—
Return 1Y-16.77%
Return 3Y-78.55%
Return 5Y-95.84%

About ALEC

ALEC is led by CEO Arnon Rosenthal, publicly traded since 2019.

ALEC stock trades at $2.72 with a market capitalization of $301.99M. The stock is valued at a price-to-earnings (P/E) ratio of -1.58, price-to-book of 7.83, price-to-sales of 12.78. Over the past 52 weeks the stock has ranged between $1.09 and $3.40, and currently trades 20.0% below its 52-week high.

On profitability, ALEC generates a return on equity (ROE) of -461.29%, return on capital employed of -486.67%, an operating margin of -695.24%, a net profit margin of -6.81%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides